Mariya Gabriel
European Commissioner for Digital Economy and Society @ European Commission
Sofia, Bulgaria
Mariya Gabriel is a grant investor at European Commission in Sofia focused on Biotechnology and Medical. Mariya Ivanova Gabriel is a Bulgarian politician and a member of the GERB party. She is the current European Commissioner for Digital Economy and Society. Previously, she was a Member of the European Parliament from 2009 to 2017. There, she served as Vice-President of the European People’s Party (EPP) group, Vice-President of EPP Women and head ofthe Bulgarian EPP delegation.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Mariya Gabriel invests in
Stages Mariya Gabriel invests in
Countries Mariya Gabriel invests in
Investment Focus
Industry
- Biotechnology 3 (60%)
- Medical 2 (40%)
- Hardware 1 (20%)
- Railroad 1 (20%)
- Biopharma 1 (20%)
Stage
- Grant 4 (80%)
- Debt Financing 1 (20%)
Country
- Spain 2 (40%)
- France 1 (20%)
- Poland 1 (20%)
- The Netherlands 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Orixha
|
Orixha has developped an innovative device for cooling patients within few minutes and thus improve their prognosis by using a dedicated liquid ventilator able to perform safe and efficient total liquid ventilation.This method consists in filling the lungs with liquid perfluorocarbons and due to the high gases solubility and the large pulmonarysufaces can use the lungs as heat exchanger. | $2.4M / Grant / Oct 14, 2022 | |
Methinks
|
Recent advances in artificial intelligence have made it possible for computers to understand images, sound, text and make decisions, in many cases, better and faster than humans.Methinks uses these new techniques, namely, Google's new deep learning framework, Tensorflow, to analise neuroimaging for diagnosis of brain related diseases.Wefocus on specific pathologies, like acute stroke, to obtain clinical excellence. | $2.4M / Grant / Oct 14, 2022 | |
ARTHEx Biotech
|
ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing antisense RNA treatments against genetic diseases. Our team has a strong background on drug discovery and microRNAs involvement in neuromuscular diseases. We are supported by world-renowned scientific and clinical advisors that will facilitate the successfuldevelopment of our products. | $2.4M / Grant / Oct 14, 2022 | |
Nevomo
|
Nevomo develops the next generation of High-Speed Railways (HSR), based on magnetic levitation, linear motor and autonomous control systems, which can be subsequently transformed into a vacuum version. It is the only company globally working on technology enabling a gradual implementation of Hyperloop-inspired solutions as an upgrade for therailway industry. The company has developed a unique, patent-pending magrail technology, which allows modernizing existing conventional railway lines to a standard of passive magnetic railways, reaching speed of 300 kph (186 mph) on normal lines and 415 kph (258 mph) on HSR lines. The magrail system allows keeping the functionality of conventional railways on a modernized line (railway operators can depreciate their existing rolling stock).Magrail can be subsequently transformed into a vacuum system – hyperrail, reaching speed of 600 kph (373 mph) on normal lines and 1000 kph (621 mph) on HSR lines.The third generation is hyperloop – vacuum magnetic railways built within new transportation corridors for top speed of 1200 kph (746 mph), using subsystems tested in the first two generations.Capex for retrofitting railway infrastructure to a magrail standard are estimated to ca. EUR 6-8 million per km, which is comparable to the cost of building a new highway and up to 60-70% lower than the average cost of building a new HSR line in the EU. Energy costs will be lower by ca. 13% for the speed of 300 kph (186 mph) compared to HSR, whole for the speed of 415 kph (258 mph) magrail needs the same amount of energy than HSR currently for 300 kph (186 mph). The maintenance costs will be ca. 25% lower than for HSR, due to elimination of friction of mechanical elements at high speeds.The company was founded in 2017 and until mid-2019 it submitted 8 patent applications. In the first half of 2019 it secured an EUR 3.8 million grant in Poland and raised EUR 334 thousands during the first Polish equity crowdfunding campaign on a UK-based platform Seedrs. Currently a Proof of Concept (PoC) is almost completed (ca. 50 m. long test track, which will be demonstrated in Q4.2019)., while at the turn of 2020 and 2021 a demonstration of the first full-scale prototype is planned.Corporate partners include TME Transfer Multisort Electronics and Microsoft. Key member of the R&D team is prof. Jacek F Gieras who has conducted research on Shinkansen SCMaglev at the Central Japan Railway Company. The company has got an international Advisory Board, including: Dorota Raben - expert in logistics & the former President of the Board of the Maritime Port of Gdansk SA, Amos Ron- former Director General at the Ministry of Energy and Infrastructure in Israel, and Vladas Lašas (also an early investor in Hyper Poland) who has co-founded Carbon War room together with Sir Richard Branson. | $2.8M / Grant / Mar 23, 2022 | |
AM Pharma
|
AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands. | $26.5M / Debt Financing / Mar 31, 2020 |
About European Commission
European Regional Development Fund encourages innovation, enhances regeneration, and provides support to businesses in the European Union.
European Commission Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mariya Gabriel
European Commissioner for Digital Economy and Society
|
|||
Andrus Ansip
Vice-President and Commissioner, Digital Single Market
|
|||
Aurélie Pols
Expert group member to the EU Observatory on the Online Platform Economy
|
|||
Björn-Sören Gigler
Senior Digital Innovation Officer
|
|||
Christian Kristin
EU Artificial Intelligence Alliance
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mariya Gabriel invest in?
Mariya Gabriel invests primarily in Biotechnology, Medical and Hardware startups, most often at Grant and Debt Financing stage. Most of the 5 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Mariya Gabriel last invest?
The most recent investment recorded for Mariya Gabriel closed in Oct 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
